drugset / Trial / NCT04181346
Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
RandomizedParallel-groupDouble-blindTreatment
Summary
phase II randomized, double-blind, placebo-controlled trial to investigate whether pregabalin can improve the complete control of nausea and vomiting (primary end point)
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-02-28
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 75 mg | — |
Indications
No indication recorded.